Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2026
Regulatory Filings Classification · 98% confidence The document is a standard Hong Kong Stock Exchange monthly return (Form FF301) filed under Chapter 19B Listing Rules detailing movements in authorised share capital, issued shares, public float confirmation, and share option schedules. It is a regulatory compliance submission rather than a narrative or financial report. It does not announce a specific share issue or repurchase event, nor does it contain financial statements or earnings data. This falls under general regulatory filings for listing rule compliance. Hence, it is classified as Regulatory Filings (RNS).
2026-06-03 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 26 MAY 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is an official announcement by Uni-Bio Science Group Limited detailing the poll results of resolutions voted on at its Extraordinary General Meeting (EGM). It provides specific vote counts and percentages for each ordinary resolution. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (Code: DVA).
2026-05-26 English
SECOND AMENDED AND RESTATED ARTICLES OF ASSOCIATION
Governance Information Classification · 90% confidence The document is the Second Amended and Restated Articles of Association of Uni-Bio Science Group Limited, detailing the company’s internal constitutional rules, share capital provisions, board and governance structures, meeting procedures, etc. This is clearly a governance document outlining the company’s internal rules and practices, fitting the Governance Information category (CGR).
2026-05-26 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 MAY 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 96% confidence The document is an official announcement by Uni-Bio Science Group Limited on the poll results of its Annual General Meeting held on 26 May 2026. It lists resolutions, vote counts (for/against), and percentages, clearly communicating shareholder voting outcomes. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (Code: DVA).
2026-05-26 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2026
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return filed with the Hong Kong Exchanges and Clearing Limited (HKEX) regarding movements in securities for Uni-Bio Science Group Limited. It includes information on authorized and issued share capital, share options, public float sufficiency confirmation, and confirmations pursuant to HKEX listing rules. The document is a regulatory submission about share capital and share movements, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a substantive regulatory filing. The content aligns with regulatory filings related to share capital and securities movements under HKEX rules, which fits the category of Regulatory Filings (RNS).
2026-05-04 English
Rules of the New Share Option Scheme
Share Issue/Capital Change Classification · 65% confidence The document is the full set of rules for a company’s Share Option Scheme – a detailed equity incentive plan governing grant, exercise, vesting and administration of share options. It is not a financial report, earnings release, proxy statement, nor a mere announcement. Instead, it sets out the mechanics of issuing new shares under the option scheme, fitting the category of capital structure changes. Therefore, it should be classified as a Share Issue/Capital Change (SHA).
2026-04-27 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.